These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8956353)

  • 1. Reversible hepatotoxicity of paroxetine in a patient with major depression.
    Helmchen C; Boerner RJ; Meyendorf R; Hegerl U
    Pharmacopsychiatry; 1996 Nov; 29(6):223-6. PubMed ID: 8956353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxic hepatitis associated with paroxetine.
    Colakoglu O; Tankurt E; Unsal B; Ugur F; Kupelioglu A; Buyrac Z; Akpinar Z
    Int J Clin Pract; 2005 Jul; 59(7):861-2. PubMed ID: 15963219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paroxetine: a review of clinical experience.
    Dunner D; Kumar R
    Pharmacopsychiatry; 1998 May; 31(3):89-101. PubMed ID: 9657236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paroxetine associated hepatotoxicity: a report of 3 cases and a review of the literature.
    Azaz-Livshits T; Hershko A; Ben-Chetrit E
    Pharmacopsychiatry; 2002 May; 35(3):112-5. PubMed ID: 12107856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ECG changes after paroxetine. 3 case reports].
    Erfurth A; Loew M; Dobmeier P; Wendler G
    Nervenarzt; 1998 Jul; 69(7):629-31. PubMed ID: 9715482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paroxetine. A pharmacoeconomic evaluation of its use in depression.
    Wilde MI; Whittington R
    Pharmacoeconomics; 1995 Jul; 8(1):62-81. PubMed ID: 10155603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis caused by antidepressive therapy with maprotiline and opipramol.
    Braun JS; Geiger R; Wehner H; Schäffer S; Berger M
    Pharmacopsychiatry; 1998 Jul; 31(4):152-5. PubMed ID: 9754852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Withdrawal after discontinuation of paroxetine.
    Arya DK
    Aust N Z J Psychiatry; 1996 Oct; 30(5):702. PubMed ID: 8902183
    [No Abstract]   [Full Text] [Related]  

  • 9. Paroxetine: a new serotonin reuptake inhibitor for the treatment of depression.
    Sherman TL; McDougle CJ; Price LH
    Conn Med; 1993 Sep; 57(9):587-92. PubMed ID: 8252846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paroxetine: a review.
    Bourin M; Chue P; Guillon Y
    CNS Drug Rev; 2001; 7(1):25-47. PubMed ID: 11420571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder.
    Hori H; Yoshimura R; Ueda N; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J
    World J Biol Psychiatry; 2009; 10(4 Pt 2):620-2. PubMed ID: 18609433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe hepatotoxicity with jaundice associated with paroxetine.
    Odeh M; Misselevech I; Boss JH; Oliven A
    Am J Gastroenterol; 2001 Aug; 96(8):2494-6. PubMed ID: 11513198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of depression with paroxetine in psychiatric practice in Germany: the possibilities and current limitations of drug monitoring.
    Zaninelli R; Meister W
    Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):9-20. PubMed ID: 9035223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant-induced hepatotoxicity.
    Lucena MI; Carvajal A; Andrade RJ; Velasco A
    Expert Opin Drug Saf; 2003 May; 2(3):249-62. PubMed ID: 12904104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hair loss associated with paroxetine treatment: a case report.
    Zalsman G; Sever J; Munitz H
    Clin Neuropharmacol; 1999; 22(4):246-7. PubMed ID: 10442258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe life-threatening hyponatremia during paroxetine therapy.
    Odeh M; Seligmann H; Oliven A
    J Clin Pharmacol; 1999 Dec; 39(12):1290-1. PubMed ID: 10586396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paroxetine and galactorrhea.
    Bonin B; Vandel P; Sechter D; Bizouard P
    Pharmacopsychiatry; 1997 Jul; 30(4):133-4. PubMed ID: 9271780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxetine and hepatotoxicity.
    Benbow SJ; Gill G
    BMJ; 1997 May; 314(7091):1387. PubMed ID: 9161313
    [No Abstract]   [Full Text] [Related]  

  • 19. [Adverse effects after switching to a different generic form of paroxetine: paroxetine mesylate instead of paroxetine HCl hemihydrate].
    Vergouwen AC; Bakker A
    Ned Tijdschr Geneeskd; 2002 Apr; 146(17):811-2. PubMed ID: 12014241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Severe hepatitis attributed to paroxetine (Seroxat)].
    de Man RA
    Ned Tijdschr Geneeskd; 1997 Mar; 141(11):540-2. PubMed ID: 9190513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.